Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilobradine vs Metoprolol and Placebo in Healthy Volunteers
NCT02264002Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2003
- Primary completion
- Nov 2003
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of cilobradine in angina pectoris and heart failure (HF) (7 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Changes in heart rate at rest, Changes in heart rate during exercise and 1 more. Started Feb 2003; status: completed.
02
Drugs
cilobradine
03
Conditions
angina pectorisheart failure (HF)
Beyond the preview
Go deeper on NCT02264002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02264002.